Combination therapy with enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) was associated with durable responses and ...

as likely as untreated participants to have been diagnosed with bladder cancer, which is often of higher grade in those who ...

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years ...

The FDA granted Trodelvy accelerated approval for bladder cancer in 2021, based on results that found it shrank tumors in people whose disease had progressed following treatment with chemotherapy ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...

“This is the first study to show an improvement in OS using a combination of chemotherapy and immunotherapy in patients with metastatic bladder cancer,” said Dr Apolo, who noted that earlier ...

Though they may seem like something from the future, these five cancer vaccines are available now. Here are details about who ...

Patients with muscle-invasive bladder cancer who underwent whole pelvis radiation showed improved cancer-specific survival and overall survival.

A recent study reveals that extended lymphadenectomy offers no survival advantage over standard lymphadenectomy for patients ...